Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Nuvalent, Inc. (NUVL)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 73,500,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Nuvalent is a biopharmaceutical company. Co.'s product candidate, NVL-520, is a ROS proto-oncogene 1 (ROS1)-selective inhibitor designed with the aim to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of available ROS1 tyrosine kinase inhibitors. Co.'s another product candidate, NVL-655, is a brain-penetrant anaplastic lymphoma kinase (ALK)-selective inhibitor, designed with the aim to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that may limit the use of first-, second-, and third-generation ALK inhibitors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 130,145 282,145 3,810,570 5,500,944
Total Sell Value $10,418,239 $21,517,007 $351,868,816 $472,149,511
Total People Sold 4 5 10 11
Total Sell Transactions 14 23 54 100
End Date 2025-05-18 2025-02-14 2024-08-16 2023-08-17

   
Records found: 303
  Page 1 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-08-07 4 AS $74.85 $411,675 D/D (5,500) 60,956     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-08-07 4 OE $18.93 $152,415 D/D 5,500 66,456     -
   Noci Darlene Chief Development Officer   •       –      –    2025-07-30 4 AS $80.36 $321,440 D/D (4,000) 48,034     -
   Noci Darlene Chief Development Officer   •       –      –    2025-07-30 4 OE $27.85 $111,400 D/D 4,000 52,034     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-07-16 4 AS $85.10 $1,250,970 D/D (14,700) 61,734     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-07-16 4 OE $18.93 $278,271 D/D 14,700 76,434     -
   Porter James Richard President and CEO   •       •      –    2025-07-15 4 AS $81.64 $2,221,419 D/D (27,000) 249,062     -
   Porter James Richard President and CEO   •       •      –    2025-07-15 4 OE $18.93 $511,110 D/D 27,000 276,062     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-07-15 4 AS $82.67 $442,526 D/D (5,300) 61,734     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-07-15 4 OE $18.93 $100,329 D/D 5,300 67,034     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-07-10 4 AS $79.94 $439,905 D/D (5,500) 60,956     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-07-10 4 OE $18.93 $158,123 D/D 5,500 66,456     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-07-09 4 AS $81.08 $174,081 D/D (2,145) 60,956     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-06-27 4 AS $80.02 $1,600,400 D/D (20,000) 61,734     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-06-27 4 OE $18.93 $378,600 D/D 20,000 81,734     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-06-27 4 AS $79.92 $173,426 D/D (2,170) 63,101     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-06-27 4 OE $27.85 $63,133 D/D 2,170 65,271     -
   Noci Darlene Chief Development Officer   •       –      –    2025-06-26 4 AS $77.38 $314,826 D/D (4,000) 48,034     -
   Noci Darlene Chief Development Officer   •       –      –    2025-06-26 4 OE $27.85 $111,400 D/D 4,000 52,034     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-06-25 4 AS $79.87 $689,278 D/D (8,630) 63,101     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-06-25 4 OE $27.85 $247,676 D/D 8,630 71,731     -
   Srivastava Sapna   –       •      –    2025-06-18 4 A $0.00 $0 D/D 2,647 5,146     -
   Meyers Michael L.   –       •      –    2025-06-18 4 A $0.00 $0 D/D 2,647 5,146     -
   Pearlberg Joseph   –       •      –    2025-06-18 4 A $0.00 $0 D/D 2,647 5,146     -
   Shair Matthew   –       •      –    2025-06-18 4 A $0.00 $0 D/D 2,647 1,429,844     -
  303 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us